Clinical studies recruiting near Nancy

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHRU Nancy - Hôpital Brabois - Service Hématologie · The Lymphoma Academic Research Organisation · NCT07018752 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU Nancy · Fondation Hôpital Saint-Joseph · NCT05674994 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · CHU Nancy · Princess Maxima Center for Pediatric Oncology · NCT05327894 Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics
Phase 3 · CHRU Nancy · Central Hospital, Nancy, France · NCT05512403 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · CHU de Nancy Hopitaux de Brabois · Miltenyi Biomedicine GmbH · NCT04844866 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · CHRU de Nancy - Hopitaux de Brabois · Lumara Bio Oncologics GmbH · NCT05706129 French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Nancy · University Hospital, Limoges · NCT04592003 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Centre Hospitalier Régional Universitaire de Nancy (CHRU) - · Travere Therapeutics, Inc. · NCT06247085 Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · CHRU Nancy · Nantes University Hospital · NCT06244433 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Service d'Hématologie et de Médecine interne Hôpital Brabois · University Hospital, Clermont-Ferrand · NCT04935684 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centre Hospitalier Universitaire de Nancy - Hopital de Brabo · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Merck Sharp & Dohme LLC · NCT07216703 Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · Institut de Cancérologie de Lorraine Nancy · Institut Curie · NCT04731610 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · CHU de Nancy - Brabois · The Lymphoma Academic Research Organisation · NCT06006117 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Centre Hospitalier Universitaire de Nancy - Hôpital Central · Janssen Research & Development, LLC · NCT07499232 Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke
Phase 3 · CHRU Nancy · Central Hospital, Nancy, France · NCT06768138 Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Phase 1/Phase 2 · CHRU NANCY - Hôpital d'Enfants · Centre Oscar Lambret · NCT05384821 Evaluation of Methodological and Technical DEvelopmeNts to Improve the Quality and Comfort of Magnetic Resonance Imaging
NA · CHRU de Nancy · Central Hospital, Nancy, France · NCT05218460 Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More
Phase 2 · CHRU Nancy · Assistance Publique - Hôpitaux de Paris · NCT06646497 Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Phase N/A · CHU de Nancy - Hopitaux de Brabois · RECORDATI GROUP · NCT04176523 Peripersonal Space Representation in Upper Limb Segmental Exclusion
Phase N/A · Institut Régional de Médecine Physique et de Réadaptation (I · Union de Gestion des Etablissements des Caisses d'Assurance · NCT07349173 Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
Phase 3 · CHRU Nancy · University Hospital, Toulouse · NCT05625724 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · Centre d'Oncologie de Gentilly · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213 Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · CHRU Nancy Brabois · Federation Francophone de Cancerologie Digestive · NCT07270991 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · CHRU de Nancy - Hôpitaux de Brabois · Gilead Sciences · NCT06051617 Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Phase N/A · CHRU Nancy · Gérond'if · NCT06427304 A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulc
Phase 4 · CHU Nancy - Hôpital de Brabois · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT04183608 Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors
Phase N/A · CHRU Nancy · Central Hospital, Nancy, France · NCT07413640

Look up another city

Look up another condition